Subtype
Adrenal Cortical Neoplasm
CI-CAN-00001700Explore in graph →
Non-malignant26 active trials1 approved drugs2 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001700Explore in graph →
Clinical trials
105 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00469469 | Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma | withdrawn | Phase 2 | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 22, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Apr 22, 2015source: clinicaltrials